![John S. Sundsmo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John S. Sundsmo
Geen lopende functies
Profiel
John S.
Sundsmo worked as the VP-Research & Intellectual Property Management at Stellar Biotechnologies, Inc. before obtaining a doctorate degree from the University of Washington.
Eerdere bekende functies van John S. Sundsmo
Bedrijven | Functie | Einde |
---|---|---|
Stellar Biotechnologies, Inc.
![]() Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van John S. Sundsmo
University of Washington | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Stellar Biotechnologies, Inc.
![]() Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA. | Health Technology |